We are live on
!
Find out more
EVLO
Evelo Biosciences, Inc. Common Stock
EVLO
EVLO
Delisted
EVLO was delisted on the 11th of December, 2023.
29 hedge funds and large institutions have $52M invested in Evelo Biosciences, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
700% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 2
360% more capital invested
Capital invested by funds: $11.3M → $52M (+$40.7M)
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
16% more funds holding
Funds holding: 25 → 29 (+4)
Holders
29
Holders Change
+4
Holders Change %
+16%
% of All Funds
0.46%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.05%
New
6
Increased
16
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
FP
Flagship Pioneering
Cambridge,
Massachusetts
|
+$36.9M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$15.8M |
| 3 |
HP
Harbourvest Partners
Boston,
Massachusetts
|
+$8.86M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.81M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.38M |
Top Sellers
| 1 |
Barclays
London,
United Kingdom
|
-$556K |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$6.84K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$242 |
